new oral glp 1 agonist Semaglutide Approved to Reduce the Risk of Cardiovascular Events Very cool - new trial

It helps maintain a youthful, radiant complexion

FDA approvals now encompass chronic kidney disease indications for some agents, obstructive sleep apnea treatment and metabolic dysfunction associated steatotic liver disease for select products

Nanomater 2020, Vol 10, Page 709 [Internet]

First and foremost, S Acetyl L Glutathione Powder is known for its potent antioxidant properties

However, the L-Carnitine group had a greater increase in carotid atherosclerotic stenosis of 9.3% (p = 0.02) compared to the placebo group.[15] Important Takeaway Researchers noted that while there was not a significant increase in total plaque volume following six months of L-carnitine supplementation, their findings suggest potential harm with L-Carnitine supplements, both for worsening cardiometabolic risk factors (i.e., LDL-C) and for atherosclerosis progression (i.e., stenosis), potentially contributing to arterial plaque

PMID: 25394726